Allergan, Inc. (NYSE:AGN)

investing

Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter

Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by 2.9% in the third quarter. ...
Read Full Story »
upside

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

If any sector has had a tough go of it the past year, it has been health care, and especially biotechnology. Continued harsh rhetoric from politicians, especially the Democrats, over ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

Stocks were up very slightly on Monday morning, but not enough to offset Friday's sell-off after the Clinton email situation was brought back front and center. The earnings floodgates are ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »
GettyImages_183162370

Tobira Therapeutics Skyrockets on Allergan Acquisition

Tobira Therapeutics Inc. (NASDAQ: TBRA) shares skyrocketed on Tuesday after Allergan PLC (NYSE: AGN) announced that it will acquire the company. Both boards of directors have unanimously approved the transaction ...
Read Full Story »
M&A

Vitae Shares Jump Over 150% on Allergan Acquisition

Allergan PLC (NYSE: AGN) announced early on Wednesday that it would be acquiring Vitae Pharmaceuticals Inc. (NASDAQ: VTAE). The goal of this transaction is to bolster Allergan’s dermatology product pipeline, and ...
Read Full Story »
Prescription drugs

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer Inc. (NYSE: PFE) has finally reeled in cancer-drug maker Medivation Inc. (NASDAQ: MDVN) for a whopping $81.50 a ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More

Stocks may be at all-time highs, but a lack of catalysts has shares soft on Friday. Low interest rates and a lack of other asset classes offering a return keep ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
white pills

Why Allergan Earnings Aren’t Telling the Whole Story

The big news for Allergan PLC (NYSE: AGN) came early in the second quarter, when Pfizer Inc. (NYSE: PFE) terminated its proposed $160 billion acquisition of the Ireland-based maker of Botox. ...
Read Full Story »
white pills

What Expect From Teva Earnings

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is scheduled to release its second-quarter financial results before the markets open on Thursday. This company has so far been unable to escape its rough ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Allergan, GE, HP Enterprise, Southwest Air, Williams Companies and More

Stocks hit a new high last week and were trying to open marginally higher on Monday morning. From low rates to Brexit, and from high valuations with a low VIX, ...
Read Full Story »
money

Why Teva’s $20 Billion Bond Sale Makes Sense, as Long as It’s a Fixed Rate

Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA) is about to take on a huge $20 billion to $25 billion mortgage in order to finance its takeover of the generics business of ...
Read Full Story »
Pills and tablets

Why the Teva Acquisition Proves It Is a Stock to Own for the Decade

It is no secret that drug price pressure and the winds of political change have been hurting almost every large company tied to the pharmaceutical and biotech industries. Even though ...
Read Full Story »
white pills

J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks

Ever since the infamous Hillary Clinton tweet about pharmaceutical drug pricing, the biotech and specialty pharmaceutical stocks have taken a huge beating. In some cases, the markets have knocked valuations ...
Read Full Story »